Why the report needs both hormone and visual-field results
A pituitary adenoma is not one condition. The report has to say which hormone, if any, the tumour produces, and whether the optic chiasm or optic nerves are affected. Those two pieces of information point in different directions. A hormone-secreting tumour may be managed first with medication, while a tumour compressing the visual pathways may need surgical decompression. A non-functioning tumour found by chance may only need monitoring.
This is why a report that says only 'pituitary adenoma' is not enough for a meaningful review. The treating team needs the hormone panel with units and reference ranges, the visual-field chart, and the imaging report together. If any of those is missing, the first useful step is to ask your current clinician what the results actually show, rather than sending an incomplete file and hoping the gap will be filled later.
The National Cancer Institute notes that treatment options differ by tumour type and that hormone-related treatment and follow-up are part of care. That is a general statement, not a plan for your case. Your own results decide which of those routes is even relevant.
What each hormone result can and cannot tell you
Hormone results are usually reported as a set, not a single number. Prolactin, growth hormone, cortisol-related tests, thyroid hormones and others may appear. What matters for the report is not just whether a value is high or low, but which axis is abnormal and whether the pattern is consistent with a secreting adenoma. A single elevated value can have several explanations, and a normal value does not by itself rule out a functioning tumour.
This is a point where patients often assume the report is self-explanatory. It is not. Ask your clinician to write, in plain terms, which hormone is considered abnormal, what the reference range is, and whether any confirmatory testing was done. If the report includes a suppression or stimulation test, ask what the result means. If it does not, ask whether one is needed. Do not change any medication based on your own reading of the numbers.
For an overseas review, the practical requirement is a complete hormone panel with dates, units and the laboratory's reference ranges. A summary that says 'hormones abnormal' cannot be interpreted. If earlier endocrine care was given elsewhere, include those notes too, because the trend over time can matter as much as a single result.
What visual-field testing adds that imaging alone does not
Visual-field testing maps where you can see, including the peripheral areas. A pituitary tumour that presses upward on the optic chiasm can produce a characteristic pattern of loss, often affecting the outer fields of both eyes. Imaging shows the anatomy; the visual-field chart shows the functional effect. A report that includes only an MRI impression and no field test leaves the functional question open.
This matters for the decision, not just for completeness. If the fields are normal and stable, the urgency of surgery may be different from a case with progressive field loss. If the fields are abnormal, the pattern and the rate of change are relevant to how the treating team weighs timing. Neither you nor an editorial article can make that judgement; the treating clinician must interpret the chart alongside the scan and the hormone results.
Ask for the actual visual-field printout or a clear report, not a one-line note saying 'visual fields abnormal'. If you have had more than one test, include the dates so the team can see whether the defect is stable or changing. If you have not had a field test, ask your current clinician whether one is appropriate for your situation.
How earlier endocrine care changes what the report should include
If you have already been under endocrine care, the report should not start from zero. It should state what treatment you have received, for how long, and what the response has been. A tumour that has been managed with medication for some time may look different on a new review than a newly diagnosed one. The treating team needs to know whether the current results are on treatment or off it.
This is also where gaps become a problem. If the earlier notes are in another language, a short structured summary in English is more useful than a pile of untranslated pages. The summary should list the diagnosis, the hormone results with dates, the treatment given, and the main question you want answered. It should not be a full archive, and it should not include passport numbers or payment details at the first contact.
Be clear about what you want from the review. 'Is surgery appropriate for me?' and 'Is my medication still the right approach?' are different questions and may need different specialists. A records-based opinion can address the question you actually ask; it cannot examine you or replace an in-person assessment.
Surgery and medical alternatives: what the report must support
The National Cancer Institute describes endoscopic transsphenoidal surgery, which reaches the pituitary through the nose. It also notes that treatment options differ by tumour type and that hormone-related treatment and follow-up are part of care. That is background, not a recommendation. Whether surgery, medication or monitoring is appropriate depends on the tumour type, the hormone pattern, the visual findings and your overall health.
For a review in China, the report should let a specialist see the basis for each option. If surgery is being considered, the imaging report and the visual-field result are central. If medication is being considered, the hormone results and the earlier treatment history are central. If monitoring is being considered, the trend over time is central. A report that omits one of these makes the review less useful.
Do not assume that a pituitary adenoma is cancer or that every adenoma needs an operation. Many are not cancerous, and management varies. The treating team decides suitability after reviewing the records and, where relevant, examining you. An initial enquiry does not establish eligibility for any procedure, and a records-based opinion does not replace that assessment.
Preparing the file and the questions to send
A useful first message is short. State the diagnosis as it currently stands, list the hormone results with dates and units, note whether a visual-field test was done and what it showed, and give the imaging report. Then ask one clear question. If you do not have a result, say so rather than leaving it out. The team can then tell you what is missing.
You can start with a brief summary through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require buying a proxy consultation. If a records-based opinion is arranged later, it is optional and separate from any hospital charges. Hospital consultation, testing, treatment and room costs are paid to the hospital or relevant provider, and coordination fees are separate. Ask the specific provider for a written quote that states what is included.
Before you send anything, confirm with your current clinician what the hormone and visual-field results mean for your case, and whether any further testing is needed. Do not delay necessary local care while an overseas enquiry is in progress. If your vision is worsening or you have new severe symptoms, seek local medical assessment first.
The next practical step is to gather the three core documents, ask your clinician to clarify any result you do not understand, and send a short summary with your main question. The hospital decides whether and how it can help.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.